Recent studies on the neurocognitive effects of second-generation antipsychotic medications
- 1 January 2002
- journal article
- Published by Wolters Kluwer Health in Current Opinion in Psychiatry
- Vol. 15 (1), 25-29
- https://doi.org/10.1097/00001504-200201000-00005
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Studies of Cognitive Change in Patients With Schizophrenia Following Novel Antipsychotic TreatmentAmerican Journal of Psychiatry, 2001
- Improvement in cognition associated with novel antipsychotic drugs: a direct drug effect or reduction of EPS?Schizophrenia Research, 2000
- Normal P50 Suppression in Schizophrenia Patients Treated With Atypical Antipsychotic MedicationsAmerican Journal of Psychiatry, 2000
- Reversal of Antipsychotic-Induced Working Memory Deficits by Short-Term Dopamine D1 Receptor StimulationScience, 2000
- Neurocognitive Deficits and Functional Outcome in Schizophrenia: Are We Measuring the "Right Stuff"?Schizophrenia Bulletin, 2000
- Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.Neuropsychology, 1998
- The Effects of Clozapine on Symptom Reduction, Neurocognitive Function, and Clinical Management in Treatment-Refractory State Hospital Schizophrenic InpatientsNeuropsychopharmacology, 1996
- Assessing the Validity of an Animal Model of Deficient Sensorimotor Gating in Schizophrenic PatientsArchives of General Psychiatry, 1994
- Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapineBiological Psychiatry, 1993
- Neuroleptics: Effects on Neuropsychological Function in Chronic Schizophrenic PatientsSchizophrenia Bulletin, 1990